Navigation Links
Gene Therapy Shows Promise for Rare Children's Brain Disorder
Date:12/19/2012

about a decade later, all are still alive, Leone said.

In general, the gene therapy cut the children's brain levels of NAA (the chemical that goes out of control in Canavan), and slowed down their brain tissue degeneration. It also boosted their quality of life, Leone and her colleagues report in the Dec. 19 issue of the journal Science Translational Medicine.

That included small improvements in the children's muscle rigidity, sleep quality, ability to move and attentiveness. Some children started having fewer seizures.

Not all of the kids benefited equally, though, and age at treatment seems to be key.

Because no one knew how the gene therapy would work, the first several children who received it were older -- about 5 years old, on average -- and in a further state of brain degeneration. They showed the least improvement.

But as the trial continued, regulators let Leone's team treat younger children; the last few were 16 months old, on average, and included a 3-month-old. It was those younger children who showed the most benefit in terms of symptoms.

"The therapy should start as early in life as possible," Leone said.

Gene therapy, for any condition, is still experimental; no form of it is approved for use in the United States. The whole field suffered a huge setback in 1999, when a teenager participating in a clinical trial of gene therapy died from a severe immune system reaction to the cold virus used to deliver the gene.

The virus used in the current study was of a different type, considered unlikely to trigger an immune system response. None of the children had a serious immune reaction to the therapy -- though one child developed a fever and another a brain abscess after the initial surgery to infuse the gene.

"The safety findings, to me, are the most important part," said Dr. Maria Escolar, director of the program for the study of neurodevelopment in rare disorders at Children's Hospital of Pittsb
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. People with HIV hospitalized less often since combination antiretroviral drug therapy introduced
2. Shaft Medical San Diego now offers micro needle sclerotherapy to treat scary “spider” veins.
3. Churchview Supportive Living to Host Music Therapy Informational Program
4. UAlberta medical researchers discover new potential chemotherapy
5. New hormone therapy shows promise for menopausal symptoms in animal model
6. Older and younger chronic leukemia patients may need different therapy
7. Novel test identifies patients most likely to benefit from ALK inhibition therapy
8. Combo Therapy May Help Ease Sleep Apnea at High Altitude
9. Potential gene therapy approach to sickle cell disease highlighted at American Society of Hematology
10. Dr. Farshchian: Labrum Tear is Now Being Treated With Cell Therapy at the Center for Regenerative Medicine Using
11. Moffitt researchers say effective immunotherapy for melanoma hinges on blocking suppressive factors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Therapy Shows Promise for Rare Children's Brain Disorder
(Date:8/31/2015)... ... 2015 , ... On Saturday, July 11, 2015, during the annual New York ... NYSATA was proud to recognize Dr. Merritt F. Spear as the 2015 recipient of ... after long-time NYSATA member and Ithaca College athletic trainer and educator, is considered for ...
(Date:8/31/2015)... ... ... Intellitec Solutions announced they have reached a record for the number of new ... 2015. With the potential for more hiring occurring before the year end, this marks ... Dynamics CRM and Intacct, and has hired new support staff in all 4 of ...
(Date:8/31/2015)... Minneapolis, MN (PRWEB) , ... August 31, 2015 , ... ... The vasectomy has one of the lowest failure rates among birth control methods. Moreover, ... vasectomy. Still, some men hesitate to have their vasectomy done because they are ...
(Date:8/31/2015)... New York, NY (PRWEB) , ... August 31, ... ... solutions for plastic surgery, dermatology and women’s health, is proud to announce South ... system. Now expanding patient access to the most sought-after radio frequency thermotherapy ...
(Date:8/31/2015)... ... August 31, 2015 , ... GenHart Software, LLC, a rising ... to help small businesses operate as efficiently and cost effectively as possible, with a ... impact in their first year of operation – and the Charleston business community is ...
Breaking Medicine News(10 mins):Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 2Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 3Health News:Intellitec Solutions Achieves Record Pace for New Hiring 2Health News:One Stop Medical Center of Twin Cities Achieves Zero Failure Rate and Infection Rate in No Scalpel Vasectomy 2Health News:Thermi Heats Up South Korea Announcing Global Expansion with NewRegulatory Approvals for ThermiRF™ 2Health News:GenHart Software, LCC Launches Scheduling, Appointment Reminder, Text Marketing Software Designed to Help Businesses Increase Revenue While Decreasing Client Attrition 2Health News:GenHart Software, LCC Launches Scheduling, Appointment Reminder, Text Marketing Software Designed to Help Businesses Increase Revenue While Decreasing Client Attrition 3
... and 10-year survival rates continue to improve for children ... acute lymphoblastic leukemia (ALL), acute non-lymphoblastic leukemia, or non-Hodgkin ... the September 9 online issue of the Journal ... treatment for childhood hematologic malignancies have led to increased ...
... of Familial Risk Estimates Increases Estimated Melanoma Risk But ... relative risk of familial melanoma increases substantially when researchers ... cohort study. The relative risk of familial lung, breast, ... the correction. , Researchers have used the Swedish Cancer ...
... of daily calcium supplements show a marked reduction in lead ... role in reducing fetal and infant exposure. , A new ... take 1,200 milligrams of calcium daily have up to a ... lead-glazed ceramics and those with high bone lead levels showed ...
... Both higher fish consumption and longer breastfeeding are linked ... to a study of mothers and infants from Denmark. ... , "These results, together with findings from other studies ... provide additional evidence that moderate maternal fish intake during ...
... can be given in tandem with clot-dissolving drug , , ... give the clot-dissolving drug tPA to people with very ... a new study indicates. , The American Heart Association ... of tPA, tissue plasminogen activator, in such cases, "but ...
... Leadership Development and Technological Efficiency , ... ... 2008 -- http://www.jacksonhealthcare.com/companies.aspx [Jackson Healthcare] (JH) has ... http://www.locumtenens.com/new_leader08 [LocumTenens.com]. Working with the physician recruitment ...
Cached Medicine News:Health News:5- and 10-year survival continues to improve for US children with hematologic malignancies 2Health News:Also in the Sept. 9 JNCI 2Health News:Also in the Sept. 9 JNCI 3Health News:Calcium during pregnancy reduces harmful blood lead levels 2Health News:Eating fish while pregnant, longer breastfeeding, lead to better infant development 2Health News:Eating fish while pregnant, longer breastfeeding, lead to better infant development 3Health News:Blood Pressure Treatment Can Be Used Against Stroke 2Health News:R. Shane Jackson Named President of LocumTenens.com 2Health News:R. Shane Jackson Named President of LocumTenens.com 3
(Date:8/28/2015)... , Aug. 28, 2015  CytomX Therapeutics, Inc., a ... cancer, today announced the filing of a registration statement ... Commission (SEC) relating to a proposed initial public offering ... be offered and the price range for the offering ... its common stock under the symbol "CTMX" on the ...
(Date:8/28/2015)... Research and Markets ( ... "Investigation Report on China,s Tobramycin Market, 2010-2019" report ... antibiotic whose eye drop and ointment are the most ... or inflammation caused by eye infection. Currently, dozens of ... to produce tobramycin, among which the Top 5 are ...
(Date:8/28/2015)... , Aug. 28, 2015 ... has announced the addition of the "Investigation ... to their offering. Developed by Pharmacia ... prostaglandin receptor agonist which effectively reduces intraocular pressure. ... FDA, latanoprost (under the trade name of Xalatan) ...
Breaking Medicine Technology:CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Tobramycin Market, 2015-2019 2China Latanoprost Market Investigation Report 2015-2019 2
... Dec. 14, 2010 Samplify Systems, Inc., a ... the ultrasound market, is pleased to announce that ... has won Electronic Design Magazine,s Best ... category.  Details of Samplify,s AutoFocus™ beamforming technology currently ...
... 14, 2010 Pacira Pharmaceuticals, Inc. ... the New Drug Application (NDA) for EXPAREL™, a long-acting ... filing by the U.S. Food and Drug Administration (FDA). ... the initial indication of postsurgical analgesia by local administration. ...
Cached Medicine Technology:Samplify's AutoFocus™ Beamforming Technology Awarded Electronic Design's 'Best of 2010' 2
Cold light source single outlet....
... The 4150S is a state ... halogen light source with an ... standard coupler to connect optical ... source distinguishes itself from all ...
The 9300XSP is the brightest light source available. Visualize more clearly, see color more accurately, and work more effectively. Luxtecs xenon lighting delivers bright, white light that is as close...
The Carl Zeiss Head-worn Loupes L and LC are the ideal solution if a low magnification suffices for your work and you want to keep your hands free to perform the task at hand....
Medicine Products: